Join Samir Shreim, CEO of Aly Development, for a discussion on product development for scientific products Starting from a performance perspective, what are the sources of variance and how do we mitigate them?
How does clinical study fit into all of this? Finally, when to call it good enough and how that can align with business goals.
Tickets $15
Lunch will be provided for all in-person attendees.
Dr. Samir Shreim is currently CEO of Aly Development, LLC, which he founded in response to support requests during his time as CEO of Cactus Medical, LLC, a privately, NSF, NIH, and Westcoast Consortium for Technology and Innovation in Pediatrics supported start-up company focused on developing a novel LED driven multi-spectral otoscope to assess ear health in children. Dr. Shreim completed his undergraduate degree in Biomedical Engineering at the University of California, Irvine (UCI) in 2006 and began his career at Applied Medical Resources developing automated assembly equipment for Applied’s advanced laparoscopy products. He returned to UC Irvine’s Biomedical Engineering Department where he developed specialized instrumentation to conduct micromechanical studies on cells and their microenvironment on his was to earning a PhD in 2011. Dr. Shreim later worked as a sensor and algorithm engineer at Masimo Corporation where he developed advanced prototypes, expanded manufacturing capacity for FDA cleared products, and contributed to algorithms currently deployed in FDA cleared, light-based physiologic sensors worldwide.
Tuesday, September 13, 2022
12:00 PM - 01:00 PM PT
Location
University Lab Partners, 5270 California Ave., Suite 300, Irvine CA, 92617